Life Sciences

Aligning Strategies and Deliverables for Global eCOA Translation Submissions to Ethics Committees in Clinical Trials

Have you ever wondered how to best align your strategies and deliverables in clinical trials when delivering eCOA translation submissions to ethics committees? This research, selected for presentation at DIA Global in Boston, June 2018, addresses this question and proposes specific solutions.

Getting The Words Right: Device Documentation And Translation In Asia

The medical device sector has seen increasing harmonization of regulations on both a global and regional basis. Nonetheless, market-entry requirements retain a significant degree of localization, particularly in relation to product labeling and documentation. Asia is no exception. For device companies prepared to negotiate the obstacles, though, the potential rewards of a huge and diverse market are considerable.

An Investigation of Issues in the Translation and Comprehension of Disease Activity in Patient Reported Outcome (PRO) Measures

The RWS Life Sciences Linguistic Validation and Survey Analyst Teams carried out a study investigating the issues in the translation and comprehension of diseases activity in Patient Reported Outcome (PRO) measures. Learn about what the research entailed, the results of the study and concluding thoughts by viewing RWS's research poster.